Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free APLMW Stock Alerts

Apollomics (APLMW) Competitors

Apollomics logo
$0.02 +0.00 (+1.60%)
As of 07/24/2026 03:14 PM Eastern
Compare

APLMW vs. SXTPW, DRTSW, BIVIW, CDIOW, and CELUW

Should you buy Apollomics stock or one of its competitors? MarketBeat compares Apollomics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apollomics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BioVie (BIVIW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does Apollomics compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat 60 Degrees Pharmaceuticals' score of 0.93 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Positive
Apollomics Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than Apollomics. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.40 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Apollomics Very Positive

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to BioVie?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, BioVie had 2 more articles in the media than Apollomics. MarketBeat recorded 3 mentions for BioVie and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat BioVie's score of 0.91 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
BioVie Positive

Summary

Apollomics beats BioVie on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Cardio Diagnostics?

Apollomics (NASDAQ:APLMW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Cardio Diagnostics' score of 0.43 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
Cardio Diagnostics Neutral

Summary

Apollomics beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Celularity?

Apollomics (NASDAQ:APLMW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Celularity had 3 more articles in the media than Apollomics. MarketBeat recorded 4 mentions for Celularity and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Celularity's score of 0.22 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
Celularity Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Celularity N/A N/A N/A

Summary

Celularity beats Apollomics on 2 of the 3 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLMW vs. The Competition

Export
MetricApollomicsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$434.82M$6.87B$12.26B
Dividend YieldN/A3.90%2.67%9.79%
P/E RatioN/A3.1627.1423.64
Price / SalesN/A6,592.20517.0688.99
Price / CashN/A13.1350.5459.64
Price / BookN/A83.7010.286.07
Net IncomeN/A-$96.07M$3.60B$331.99M
7 Day PerformanceN/A-0.66%-1.27%-0.63%
1 Month PerformanceN/A-1.07%-0.37%-2.00%
1 Year PerformanceN/A56.07%18.30%13.62%

Apollomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLMW
Apollomics
N/A$0.02
+1.6%		N/A-38.5%$0.00$8.50MN/A59
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-64.6%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.76
+0.3%		N/A+1,259.0%$0.00N/AN/A80
BIVIW
BioVie
N/A$0.44
-0.5%		N/AN/A$0.00N/AN/AN/A
CDIOW
Cardio Diagnostics
N/A$0.02
flat		N/A-0.7%$0.00$16.57KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:APLMW) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely | Sponsoredtc pixel